Mosquito-Borne Infections Testing Market Report 2026

Mosquito-Borne Infections Testing Market Overview

• Mosquito-Borne Infections Testing market size has reached to $1.44 billion in 2025 • Expected to grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Rising Incidence Of Dengue Diseases Driving The Market Growth Due To Increasing Exposure And Need For Early Detection • Market Trend: Automated High-Throughput Immunoassays Driving Efficiency • Asia-Pacific was the largest region in 2025 and Latin America is the fastest growing region.

What Is Covered Under Mosquito-Borne Infections Testing Market?

Mosquito-borne infections testing involves detecting viruses, parasites, or bacteria transmitted by mosquitoes that cause diseases in humans. It analyzes clinical samples such as blood or serum to confirm infections, identify the specific pathogen, and assess the severity of the disease, providing crucial information for timely and effective treatment as well as for implementing targeted public health measures to control outbreaks. The main test types of mosquito-borne infections testing include molecular diagnostic tests, serological tests, rapid antigen tests, polymerase chain reaction (PCR) testing services, and laboratory reagent-based tests. Molecular diagnostic tests refer to advanced laboratory techniques used to detect genetic material of pathogens causing mosquito-borne diseases. The different sample types include blood samples, serum samples, plasma samples, urine samples, and saliva samples and the various infection types involved are dengue, malaria, zika virus, chikungunya, west nile virus, and other infection types. The different technologies include enzyme-linked immunosorbent assay, lateral flow assay, polymerase chain reaction, next-generation sequencing, and other technologies, and they are used by several end users such as hospitals and clinics, diagnostic laboratories, public health agencies, research institutes, and point-of-care settings.

What Is The Mosquito-Borne Infections Testing Market Growth Forecast?

The mosquito-borne infections testing market size is expected to see strong growth in the next few years.It will grow to $2.12 billion by 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to climate change driven expansion of mosquito habitats and disease transmission zones, increasing adoption of rapid molecular diagnostic technologies, growth in real time outbreak monitoring and predictive surveillance systems, rising demand for integrated public health data reporting systems, expansion of personalized and precision infectious disease diagnostics.Major trends in the forecast period include rising incidence of mosquito-borne outbreaks driving demand for rapid diagnostic testing, expansion of decentralized and point-of-care testing in rural and remote regions, increasing adoption of multiplex assays for simultaneous detection of multiple vector-borne pathogens, growing government-led surveillance and screening programs for early outbreak detection, rising preference for portable and field-deployable diagnostic kits for faster epidemic response.

Global Mosquito-Borne Infections Testing Market Segmentation

1) By Test Type: Molecular Diagnostic Tests, Serological Tests, Rapid Antigen Tests, Polymerase Chain Reaction (PCR) Testing Services, Laboratory Reagent-Based Tests 2) By Sample Type: Blood Samples, Serum Samples, Plasma Samples, Urine Samples, Saliva Samples 3) By Infection Type: Dengue, Malaria, Zika Virus, Chikungunya, West Nile Virus, Other Infection Types 4) By Technology: Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Polymerase Chain Reaction, Next-Generation Sequencing, Other Technologies 5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Public Health Agencies, Research Institutes, Point-Of-Care Settings Subsegments: 1) By Molecular Diagnostic Tests: Nucleic Acid Amplification Testing, Reverse Transcription Polymerase Chain Reaction Testing, Multiplex Molecular Testing, Isothermal Amplification Testing, Pathogen Specific Genetic Testing 2) By Serological Tests: Immunoglobulin M Antibody Testing, Immunoglobulin G Antibody Testing, Antigen Detection Testing, Neutralization Assays, Enzyme Immunoassay Testing 3) By Rapid Antigen Tests: Point Of Care Antigen Testing, Lateral Flow Antigen Testing, Immunochromatographic Antigen Testing, Portable Rapid Diagnostic Testing, Field Based Antigen Testing 4) By Polymerase Chain Reaction Testing Services: Real Time Polymerase Chain Reaction Testing, Quantitative Polymerase Chain Reaction Testing, Multiplex Polymerase Chain Reaction Testing, Digital Polymerase Chain Reaction Testing, Reverse Transcription Polymerase Chain Reaction Testing 5) By Laboratory Reagent Based Tests: Reagent Kit Based Diagnostic Testing, Chemical Reaction Based Testing, Enzyme Reagent Testing, Staining Reagent Testing, Buffer Solution Based Testing

What Are The Drivers Of The Mosquito-Borne Infections Testing Market?

The rising incidence of dengue diseases is expected to propel the growth of the Mosquito Borne Infections Testing market going forward.Dengue is a mosquito borne viral infection caused by the dengue virus and transmitted primarily by aedes mosquitoes.The incidence of dengue diseases is rising due to warmer temperatures and increased rainfall, which create favourable breeding conditions for aedes mosquitoes, combined with rapid urbanization that increases human exposure to mosquito populations.Mosquito‑borne infections testing helps in the early detection and monitoring of dengue infections by identifying the presence of the virus in patients, enabling timely medical intervention and public health measures to control the spread of the disease.For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, Brazil documented that of the 2,376,522 dengue cases recorded up to epidemiological week 26, 1,051,773 (44.2%) were laboratory-confirmed, and 1,249 (0.05%) were classified as severe dengue, reflecting a 13% increase compared to the same period in 2022.Therefore, the rising incidence of dengue diseases is driving the growth of the mosquito borne infections testing market. The rising international travel and trade is expected to propel the growth of the mosquito borne infections testing market going forward.International travel and trade refer to the movement of people and goods across countries for purposes such as tourism, business, and global commerce.International travel and trade are growing due to the easing of COVID‑19 restrictions, which has allowed more people to travel globally and boosted the flow of goods between countries.International travel and trade increase the movement of people and goods between regions, which can introduce mosquito-borne pathogens to new areas, making it essential to monitor and test for these infections to prevent outbreaks.For instance, in May 2024, according to the National Travel and Tourism Office (NTTO), a US‑based federal government agency, total international visitor arrivals of 66.5 million in 2023 increased by 15.7 million from 50.8 million in 2022, highlighting a significant rise in global travel.Therefore, the rising international travel and trade is driving the growth of the mosquito‑borne infections testing market.

Key Players In The Global Mosquito-Borne Infections Testing Market

Major companies operating in the mosquito-borne infections testing market are F. Hoffmann-La Roche Ltd, Trinity Biotech plc, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Grifols S. A., Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N. V., DiaSorin S. p. A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc., J. Mitra and Co. Pvt. Ltd., Today's Clinical Lab Pvt. Ltd., Co-Dx Inc.

Global Mosquito-Borne Infections Testing Market Trends and Insights

Major companies operating in the mosquito-borne infections testing market are focusing on developing innovative methods such as, automated high-throughput immunoassays to deliver faster, more accurate, and scalable detection of mosquito-borne pathogens. Automated high-throughput immunoassays are laboratory tests that automatically detect specific antigens or antibodies in large numbers of samples, helping provide rapid, accurate, and scalable diagnosis of mosquito-borne infections compared to traditional manual tests. For instance, in October 2025, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics company, received CE mark for its Elecsys Dengue Ag test, an innovative automated immunoassay designed to detect the NS1 antigen of the dengue virus in human serum and plasma. This test operates on Roche’s fully automated cobas e analysers, providing results in just 18 minutes and reliably detecting all four dengue virus serotypes. Key features include high clinical sensitivity and specificity, medium-to-high throughput of 120–300 tests per hour, enhanced traceability, and workflow efficiency, making it particularly useful during dengue outbreaks for rapid patient management and surveillance. The elecsys dengue ag test represents a significant advancement over conventional methods, delivering consistent, fast, and comprehensive diagnostic capabilities across the entire patient journey.

Regional Insights

Asia-Pacific was the largest region in the mosquito-borne infections testing market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mosquito-Borne Infections Testing Market?

The mosquito-borne infections testing market consists of revenues earned by entities by providing services such as vector surveillance and mosquito population monitoring, laboratory research and outbreak management, preventive screening, outbreak tracking and reporting, and public health consultation and planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The mosquito-borne infections testing market also includes sales of serological assay kits, rapid test kits, reagents and consumables, and laboratory equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Mosquito-Borne Infections Testing Industry?

The mosquito-borne infections testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne infections testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Mosquito-Borne Infections Testing Market Report 2026?

The mosquito-borne infections testing market research report is one of a series of new reports from The Business Research Company that provides mosquito-borne infections testing market statistics, including mosquito-borne infections testing industry global market size, regional shares, competitors with a mosquito-borne infections testing market share, detailed mosquito-borne infections testing market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne infections testing industry. This mosquito-borne infections testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.